168 related articles for article (PubMed ID: 31846091)
1. Histone deacetylase activity and vitamin D-dependent gene expressions in relation to sulforaphane in human breast cancer cells.
Hossain S; Liu Z; Wood RJ
J Food Biochem; 2020 Feb; 44(2):e13114. PubMed ID: 31846091
[TBL] [Abstract][Full Text] [Related]
2. Association between histone deacetylase activity and vitamin D-dependent gene expressions in relation to sulforaphane in human colorectal cancer cells.
Hossain S; Liu Z; Wood RJ
J Sci Food Agric; 2021 Mar; 101(5):1833-1843. PubMed ID: 32964464
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation.
Paul B; Li Y; Tollefsbol TO
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899271
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial epigenetic mechanisms of sulforaphane, genistein and sodium butyrate in breast cancer inhibition.
Sharma M; Tollefsbol TO
Exp Cell Res; 2022 Jul; 416(1):113160. PubMed ID: 35447103
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative signalling by 1,25(OH)2D3 in prostate and breast cancer is suppressed by a mechanism involving histone deacetylation.
Banwell CM; Singh R; Stewart PM; Uskokovic MR; Campbell MJ
Recent Results Cancer Res; 2003; 164():83-98. PubMed ID: 12899515
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D in thyroid tumorigenesis and development.
Clinckspoor I; Verlinden L; Mathieu C; Bouillon R; Verstuyf A; Decallonne B
Prog Histochem Cytochem; 2013 Aug; 48(2):65-98. PubMed ID: 23890557
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphane attenuates cisplatin-induced hearing loss by inhibiting histone deacetylase expression.
Wang J; Tian KY; Fang Y; Chang HM; Han YN; Chen FQ
Int J Immunopathol Pharmacol; 2021; 35():20587384211034086. PubMed ID: 34344210
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells.
Nair S; Hebbar V; Shen G; Gopalakrishnan A; Khor TO; Yu S; Xu C; Kong AN
Pharm Res; 2008 Feb; 25(2):387-99. PubMed ID: 17657594
[TBL] [Abstract][Full Text] [Related]
9. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase.
Myzak MC; Karplus PA; Chung FL; Dashwood RH
Cancer Res; 2004 Aug; 64(16):5767-74. PubMed ID: 15313918
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
Seuter S; Pehkonen P; Heikkinen S; Carlberg C
Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
[TBL] [Abstract][Full Text] [Related]
11. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427
[TBL] [Abstract][Full Text] [Related]
12. Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs.
Okonkwo A; Mitra J; Johnson GS; Li L; Dashwood WM; Hegde ML; Yue C; Dashwood RH; Rajendran P
Mol Nutr Food Res; 2018 Sep; 62(18):e1800228. PubMed ID: 29924908
[TBL] [Abstract][Full Text] [Related]
13. The natural chemopreventive agent sulforaphane inhibits STAT5 activity.
Pinz S; Unser S; Rascle A
PLoS One; 2014; 9(6):e99391. PubMed ID: 24910998
[TBL] [Abstract][Full Text] [Related]
14. HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells.
Cao C; Wu H; Vasilatos SN; Chandran U; Qin Y; Wan Y; Oesterreich S; Davidson NE; Huang Y
Int J Cancer; 2018 Sep; 143(6):1388-1401. PubMed ID: 29633255
[TBL] [Abstract][Full Text] [Related]
15. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention.
Ho E; Clarke JD; Dashwood RH
J Nutr; 2009 Dec; 139(12):2393-6. PubMed ID: 19812222
[TBL] [Abstract][Full Text] [Related]
16. The role of vitamin D in breast cancer risk and progression.
Vanhevel J; Verlinden L; Doms S; Wildiers H; Verstuyf A
Endocr Relat Cancer; 2022 Jan; 29(2):R33-R55. PubMed ID: 34935629
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic weapons in plant-herbivore interactions: Sulforaphane disrupts histone deacetylases, gene expression, and larval development in Spodoptera exigua while the specialist feeder Trichoplusia ni is largely resistant to these effects.
Somers DJ; Kushner DB; McKinnis AR; Mehmedovic D; Flame RS; Arnold TM
PLoS One; 2023; 18(10):e0293075. PubMed ID: 37856454
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms for the Inhibition of Colon Cancer Cells by Sulforaphane through Epigenetic Modulation of MicroRNA-21 and Human Telomerase Reverse Transcriptase (hTERT) Down-regulation.
Martin SL; Kala R; Tollefsbol TO
Curr Cancer Drug Targets; 2018; 18(1):97-106. PubMed ID: 28176652
[TBL] [Abstract][Full Text] [Related]
19. Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines.
Reichrath S; Müller CS; Gleissner B; Pfreundschuh M; Vogt T; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):420-4. PubMed ID: 20206691
[TBL] [Abstract][Full Text] [Related]
20. Regulation of RANKL promoter activity is associated with histone remodeling in murine bone stromal cells.
Fan X; Roy EM; Murphy TC; Nanes MS; Kim S; Pike JW; Rubin J
J Cell Biochem; 2004 Nov; 93(4):807-18. PubMed ID: 15389882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
